The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Clobazam-Global Market Insights and Sales Trends 2024
Synopsis
Clobazam (marketed under the brand names Frisium, Urbanol, Onfi, and Tapclob ) is a benzodiazepine class medication that was patented in 1968 and has been marketed as an anxiolytic since 1975 and an anticonvulsant since 1984.
The global Clobazam market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Clobazam in various end use industries. The expanding demands from the Adults, Geriatric and Children,, are propelling Clobazam market. 10mg/Pcs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 20mg/Pcs segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Clobazam market, driven by demand from China, the second largest economy with some signs of stabilising, the Clobazam market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clobazam, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clobazam market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clobazam market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clobazam sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clobazam covered in this report include Lupin Pharmaceuticals, ROSEMONT Pharma, Amneal, Merck KGaA, Breckenridge Pharmaceutical, Upsher-Smith and Hikma, etc.
The global Clobazam market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lupin Pharmaceuticals
ROSEMONT Pharma
Amneal
Merck KGaA
Breckenridge Pharmaceutical
Upsher-Smith
Hikma
Global Clobazam market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clobazam market, Segment by Type:
10mg/Pcs
20mg/Pcs
Global Clobazam market, by Application
Adults
Geriatric
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Clobazam manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Clobazam in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Clobazam (marketed under the brand names Frisium, Urbanol, Onfi, and Tapclob ) is a benzodiazepine class medication that was patented in 1968 and has been marketed as an anxiolytic since 1975 and an anticonvulsant since 1984.
The global Clobazam market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Clobazam in various end use industries. The expanding demands from the Adults, Geriatric and Children,, are propelling Clobazam market. 10mg/Pcs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 20mg/Pcs segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Clobazam market, driven by demand from China, the second largest economy with some signs of stabilising, the Clobazam market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clobazam, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clobazam market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clobazam market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clobazam sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clobazam covered in this report include Lupin Pharmaceuticals, ROSEMONT Pharma, Amneal, Merck KGaA, Breckenridge Pharmaceutical, Upsher-Smith and Hikma, etc.
The global Clobazam market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lupin Pharmaceuticals
ROSEMONT Pharma
Amneal
Merck KGaA
Breckenridge Pharmaceutical
Upsher-Smith
Hikma
Global Clobazam market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clobazam market, Segment by Type:
10mg/Pcs
20mg/Pcs
Global Clobazam market, by Application
Adults
Geriatric
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Clobazam manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Clobazam in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Clobazam Market Overview
1.1 Clobazam Product Overview
1.2 Clobazam Market Segment by Type
1.2.1 10mg/Pcs
1.2.2 20mg/Pcs
1.3 Global Clobazam Market Size by Type
1.3.1 Global Clobazam Market Size Overview by Type (2018-2029)
1.3.2 Global Clobazam Historic Market Size Review by Type (2018-2023)
1.3.3 Global Clobazam Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Clobazam Sales Breakdown by Type (2018-2023)
1.4.2 Europe Clobazam Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Clobazam Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Clobazam Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Clobazam Sales Breakdown by Type (2018-2023)
2 Global Clobazam Market Competition by Company
2.1 Global Top Players by Clobazam Sales (2018-2023)
2.2 Global Top Players by Clobazam Revenue (2018-2023)
2.3 Global Top Players by Clobazam Price (2018-2023)
2.4 Global Top Manufacturers Clobazam Manufacturing Base Distribution, Sales Area, Product Type
2.5 Clobazam Market Competitive Situation and Trends
2.5.1 Clobazam Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Clobazam Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clobazam as of 2022)
2.7 Date of Key Manufacturers Enter into Clobazam Market
2.8 Key Manufacturers Clobazam Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Clobazam Status and Outlook by Region
3.1 Global Clobazam Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Clobazam Historic Market Size by Region
3.2.1 Global Clobazam Sales in Volume by Region (2018-2023)
3.2.2 Global Clobazam Sales in Value by Region (2018-2023)
3.2.3 Global Clobazam Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Clobazam Forecasted Market Size by Region
3.3.1 Global Clobazam Sales in Volume by Region (2024-2029)
3.3.2 Global Clobazam Sales in Value by Region (2024-2029)
3.3.3 Global Clobazam Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Clobazam by Application
4.1 Clobazam Market Segment by Application
4.1.1 Adults
4.1.2 Geriatric
4.1.3 Children
4.2 Global Clobazam Market Size by Application
4.2.1 Global Clobazam Market Size Overview by Application (2018-2029)
4.2.2 Global Clobazam Historic Market Size Review by Application (2018-2023)
4.2.3 Global Clobazam Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Clobazam Sales Breakdown by Application (2018-2023)
4.3.2 Europe Clobazam Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Clobazam Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Clobazam Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Clobazam Sales Breakdown by Application (2018-2023)
5 North America Clobazam by Country
5.1 North America Clobazam Historic Market Size by Country
5.1.1 North America Clobazam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Clobazam Sales in Volume by Country (2018-2023)
5.1.3 North America Clobazam Sales in Value by Country (2018-2023)
5.2 North America Clobazam Forecasted Market Size by Country
5.2.1 North America Clobazam Sales in Volume by Country (2024-2029)
5.2.2 North America Clobazam Sales in Value by Country (2024-2029)
6 Europe Clobazam by Country
6.1 Europe Clobazam Historic Market Size by Country
6.1.1 Europe Clobazam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Clobazam Sales in Volume by Country (2018-2023)
6.1.3 Europe Clobazam Sales in Value by Country (2018-2023)
6.2 Europe Clobazam Forecasted Market Size by Country
6.2.1 Europe Clobazam Sales in Volume by Country (2024-2029)
6.2.2 Europe Clobazam Sales in Value by Country (2024-2029)
7 Asia-Pacific Clobazam by Region
7.1 Asia-Pacific Clobazam Historic Market Size by Region
7.1.1 Asia-Pacific Clobazam Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Clobazam Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Clobazam Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Clobazam Forecasted Market Size by Region
7.2.1 Asia-Pacific Clobazam Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Clobazam Sales in Value by Region (2024-2029)
8 Latin America Clobazam by Country
8.1 Latin America Clobazam Historic Market Size by Country
8.1.1 Latin America Clobazam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Clobazam Sales in Volume by Country (2018-2023)
8.1.3 Latin America Clobazam Sales in Value by Country (2018-2023)
8.2 Latin America Clobazam Forecasted Market Size by Country
8.2.1 Latin America Clobazam Sales in Volume by Country (2024-2029)
8.2.2 Latin America Clobazam Sales in Value by Country (2024-2029)
9 Middle East and Africa Clobazam by Country
9.1 Middle East and Africa Clobazam Historic Market Size by Country
9.1.1 Middle East and Africa Clobazam Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Clobazam Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Clobazam Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Clobazam Forecasted Market Size by Country
9.2.1 Middle East and Africa Clobazam Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Clobazam Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Lupin Pharmaceuticals
10.1.1 Lupin Pharmaceuticals Company Information
10.1.2 Lupin Pharmaceuticals Introduction and Business Overview
10.1.3 Lupin Pharmaceuticals Clobazam Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Lupin Pharmaceuticals Clobazam Products Offered
10.1.5 Lupin Pharmaceuticals Recent Development
10.2 ROSEMONT Pharma
10.2.1 ROSEMONT Pharma Company Information
10.2.2 ROSEMONT Pharma Introduction and Business Overview
10.2.3 ROSEMONT Pharma Clobazam Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ROSEMONT Pharma Clobazam Products Offered
10.2.5 ROSEMONT Pharma Recent Development
10.3 Amneal
10.3.1 Amneal Company Information
10.3.2 Amneal Introduction and Business Overview
10.3.3 Amneal Clobazam Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Amneal Clobazam Products Offered
10.3.5 Amneal Recent Development
10.4 Merck KGaA
10.4.1 Merck KGaA Company Information
10.4.2 Merck KGaA Introduction and Business Overview
10.4.3 Merck KGaA Clobazam Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck KGaA Clobazam Products Offered
10.4.5 Merck KGaA Recent Development
10.5 Breckenridge Pharmaceutical
10.5.1 Breckenridge Pharmaceutical Company Information
10.5.2 Breckenridge Pharmaceutical Introduction and Business Overview
10.5.3 Breckenridge Pharmaceutical Clobazam Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Breckenridge Pharmaceutical Clobazam Products Offered
10.5.5 Breckenridge Pharmaceutical Recent Development
10.6 Upsher-Smith
10.6.1 Upsher-Smith Company Information
10.6.2 Upsher-Smith Introduction and Business Overview
10.6.3 Upsher-Smith Clobazam Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Upsher-Smith Clobazam Products Offered
10.6.5 Upsher-Smith Recent Development
10.7 Hikma
10.7.1 Hikma Company Information
10.7.2 Hikma Introduction and Business Overview
10.7.3 Hikma Clobazam Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hikma Clobazam Products Offered
10.7.5 Hikma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Clobazam Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Clobazam Industrial Chain Analysis
11.4 Clobazam Market Dynamics
11.4.1 Clobazam Industry Trends
11.4.2 Clobazam Market Drivers
11.4.3 Clobazam Market Challenges
11.4.4 Clobazam Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Clobazam Distributors
12.3 Clobazam Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
